Nath Bio-Genes (India) Share PriceNath Bio-Genes (India)

₹205.95
-1.8 (-0.87%)
As on 27 September, 2023 | 16:32 BSE: 537291 NSE: NATHBIOGENISIN: INE448G01010

Nath Bio-Genes (India) Performance

Day Range

  • Low 205
  • High 210
205.95

52 Week Range

  • Low 128.85
  • High 244.6
205.95
  • Open Price205.65
  • Previous Close207.75
  • Volume32697

Start SIP in Nath Bio-Genes (India)

Start SIP

Nath Bio-Genes (India) Share Price

  • Over 1 Month -2.97%
  • Over 3 Month 9.32%
  • Over 6 Month 45.81%
  • Over 1 Year 29.24%

Nath Bio-Genes (India) Key Statistics

P/E Ratio 10.4
PEG Ratio 0.1
Market Cap Cr 391
Price to Book Ratio 0.7
EPS 18.5
Dividend 1
Relative Strength Index 44.37
Money Flow Index 64.41
MACD Signal -0.29
Average True Range 9

Nath Bio-Genes (India) Investment Rating

  • Master Rating:
  • Nath Bio Genes India has an operating revenue of Rs. 952.71 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 12% is healthy, ROE of 6% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 16% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 69 which is a FAIR score but needs to improve its earnings, a RS Rating of 62 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 134 indicates it belongs to a poor industry group of Agricultural Operations and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock definitely has some strength, you may want to examine it in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Nath Bio-Genes (India) Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 23545252220927
Operating Expenses Qtr Cr 19841201717548
Operating Profit Qtr Cr 3746534-21
Depreciation Qtr Cr 111111
Interest Qtr Cr 323332
Tax Qtr Cr 001003
Net Profit Qtr Cr 3321131-116
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 302280
Operating Expenses Annual Cr 252241
Operating Profit Annual in Cr 4937
Depreciation Cr 33
Interest Annual Cr 1011
Tax Annual Cr 14
Net Profit Annual Cr 35-67
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 3817
Cash from Investing Activity Annual Cr -3-20
Cash from Financing Annual Activity Cr -2-22
Net Cash Flow Annual Cr 34-25
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 573542
Fixed Assets Annual Cr 244245
Total Non Current Assets Annual Cr 272272
Total Current Assets Annual Cr 521470
Total Assets Annual Cr 793742
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 302285
ROE Annual % 6-12
ROCE Annual % 87
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1614
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 235
Operating Expenses Qtr Cr 198
Operating Profit Qtr Cr 37
Depreciation Qtr Cr 1
Interest Qtr Cr 3
Tax Qtr Cr 0
Net Profit Qtr Cr 33
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 302280
Operating Expenses Annual Cr 253241
Operating Profit Annual in Cr 4937
Depreciation Cr 33
Interest Annual Cr 1011
Tax Annual Cr 14
Net Profit Annual Cr 35-67
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 3817
Cash from Investing Activity Annual Cr -3-20
Cash from Financing Annual Activity Cr -2-22
Net Cash Flow Annual Cr 34-25
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 573542
Fixed Assets Annual Cr 244245
Total Non Current Assets Annual Cr 272272
Total Current Assets Annual Cr 521468
Total Assets Annual Cr 793739
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 302285
ROE Annual % 6-12
ROCE Annual % 87
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1614

Nath Bio-Genes (India) Technicals

EMA & SMA

Current Price
₹205.95
-1.8 (-0.87%)
  • Bullish Moving Average
  • ___
  • 5
  • Bearish Moving Average
  • ___
  • 11
  • 20 Day
  • ₹213.39
  • 50 Day
  • ₹211.23
  • 100 Day
  • ₹201.09
  • 200 Day
  • ₹191.45
  • 20 Day
  • ₹213.97
  • 50 Day
  • ₹215.97
  • 100 Day
  • ₹199.59
  • 200 Day
  • ₹177.59

Nath Bio-Genes (India) Resistance and Support

PIVOT
₹207.97
Resistance
First Resistance ₹210.89
Second Resistance ₹214.02
Third Resistance ₹216.94
RSI 44.37
MFI 64.41
MACD Single Line -0.28
MACD -1.6
Support
First Resistance ₹204.84
Second Resistance ₹201.92
Third Resistance ₹198.79

Nath Bio-Genes (India) Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 42,566 2,562,048 60.19
Week 59,014 3,187,925 54.02
1 Month 103,370 5,661,583 54.77
6 Month 77,517 4,087,489 52.73

Nath Bio-Genes (India) Result Highlights

Nath Bio-Genes (India) Synopsis

NSE-Agricultural Operations

Nath Bio-Genes is involved in the business activities of Growing of non-perennial crops. Company’s Total Operating Revenue is Rs. 301.29 Cr. and Equity Capital is Rs. 19.00 Cr. for the Year ended 31/03/2023. Nath Bio-Genes (India) Ltd. is a Public Limited Listed company incorporated on 14/07/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L01110MH1993PLC072842 and registration number is 072842.
Market Cap 390
Sales 327
Shares in Float 1.03
No of funds 12
Yield 0.96
Book Value 0.69
U/D Vol ratio 1.4
LTDebt / Equity
Alpha 0.07
Beta 0.97

Nath Bio-Genes (India)

Owner NameJun-23Mar-23Dec-22Sep-22
Promoters 45.6%45.6%45.6%45.6%
Mutual Funds 4.62%4.62%4.62%4.62%
Foreign Portfolio Investors 0.07%0.13%0.15%0.01%
Financial Institutions/ Banks
Individual Investors 30.37%30.17%30.62%31.61%
Others 19.34%19.48%19.01%18.16%

Nath Bio-Genes (India) Management

Name Designation
Mr. Satish Kagliwal Managing Director
Mr. Madhukar Deshpande Director
Ms. Ashu Jain Director
Mrs. Jeevanlata Kagliwal Director
Mr. Vadla Nagabhushanam Director
Mrs. Sweta Kagliwal Director
Mr. Hitesh Purohit Director

Nath Bio-Genes (India) Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Nath Bio-Genes (India) Corporate Action

Date Purpose Remarks
2023-08-10 Quarterly Results
2023-04-22 Audited Results & Final Dividend
2023-02-14 Quarterly Results
2022-10-20 Quarterly Results
2022-08-13 Quarterly Results

Nath Bio-Genes (India) MF Shareholding

Name Amount(cr)
Aditya Birla Sun Life Pure Value Fund Growth 4697
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Nath Bio-Genes (India) FAQs

What is Share Price of Nath Bio-Genes (India) ?

Nath Bio-Genes (India) share price is ₹205 As on 27 September, 2023 | 16:18

What is the Market Cap of Nath Bio-Genes (India) ?

The Market Cap of Nath Bio-Genes (India) is ₹391.4 Cr As on 27 September, 2023 | 16:18

What is the P/E ratio of Nath Bio-Genes (India) ?

The P/E ratio of Nath Bio-Genes (India) is 10.4 As on 27 September, 2023 | 16:18

What is the PB ratio of Nath Bio-Genes (India) ?

The PB ratio of Nath Bio-Genes (India) is 0.7 As on 27 September, 2023 | 16:18

Q2FY23